• About
  • Privacy Poilicy
  • Disclaimer
  • Contact
CoinInsight
  • Home
  • Bitcoin
  • Ethereum
  • Regulation
  • Market
  • Blockchain
  • Ripple
  • Future of Crypto
  • Crypto Mining
No Result
View All Result
  • Home
  • Bitcoin
  • Ethereum
  • Regulation
  • Market
  • Blockchain
  • Ripple
  • Future of Crypto
  • Crypto Mining
No Result
View All Result
CoinInsight
No Result
View All Result
Home Market

Down 29% regardless of sturdy full-year outcomes and 32% forecast annual progress, this FTSE 250 nanotech agency seems a hidden gem to me

Coininsight by Coininsight
June 26, 2025
in Market
0
Down 29% regardless of sturdy full-year outcomes and 32% forecast annual progress, this FTSE 250 nanotech agency seems a hidden gem to me
189
SHARES
1.5k
VIEWS
Share on FacebookShare on Twitter


Person holding magnifying glass over important document, reading the small print

Picture supply: Getty Photos

FTSE 250 hi-tech agency Oxford Devices (LSE: OXIG) is down 29% from its 15 July one-year traded excessive of £26.

It was established in 1959 when it was spun off from Oxford College’s physics division. An early success was its pioneering function within the improvement of magnetic resonance imaging scans utilized in medical prognosis.

Since then it has been on the slicing fringe of the design and manufacture of high-tech merchandise for scientific and industrial use.

Most notably maybe, it’s a world chief in nanotechnology. This includes manipulating matter on the atomic and molecular stage to create new supplies and units. 

Why has the share worth dropped?

A key motive behind its current share worth decline was information that it has agreed to promote its NanoScience enterprise.

Nevertheless, it is very important observe that this solely contains a part of the agency’s nanotechnology pursuits. Particularly, the bit that makes particular models to supercool quantum computer systems.

The agency highlights that the sale will enhance its margin by 1.9% enhance by permitting it to deal with three core structural progress markets. These are supplies evaluation, semiconductor, and healthcare & life science.

Furthermore, as much as £50m of the proceeds from the divestment will go to a share buyback. These are usually supportive of share worth positive aspects.

The newest outcomes

The agency’s full fiscal 12 months 2024/25 outcomes noticed income rise 6.5% 12 months on 12 months to £500.6m. This was the primary time income had breached the £500m barrier.

Working revenue elevated 10.8% to £82.2m, whereas adjusted revenue margin edged up 0.7% to 17.8%.

Income is a agency’s complete revenue, whereas earnings (or ‘revenue’) are what stays after bills have been deducted.

A threat for the agency is a significant failure in considered one of its key merchandise. This may harm its popularity and be expensive to repair.

That stated, consensus analysts’ forecasts are that its earnings will rise by a whopping 32.4% every year to end-fiscal 12 months 2027/28.

Are the shares undervalued?

The primary a part of my evaluation of the agency’s share worth is to match its key valuations with these of its rivals.

On the price-to-sales ratio, Oxford Devices’ 2.1 studying is undervalued in comparison with its friends’ common of two.7. These comprise Bruker at 1.7, Renishaw at 2.8. Spectris at 2.9, and Thermo Fisher Scientific at 3.5.

Nevertheless, it seems overvalued at a price-to-earnings ratio of 39.7 in comparison with its peer group’s 33.3 common.

The second a part of my evaluation includes operating a discounted money circulation (DCF) evaluation. That is primarily based on money circulation forecasts for the underlying enterprise and pinpoints the place any agency’s share worth must be.

Utilizing different analysts’ figures and my very own, the DCF for Oxford Devices reveals its shares are 40% undervalued at £18.44.

Due to this fact, their truthful worth is £30.73.

My view

I’m often centered on shares that ship a excessive dividend yield, whereas Oxford Devices solely pays 1.2% at current.

Nevertheless, its very sturdy earnings progress potential ought to energy its share worth and dividend a lot larger over time.

I additionally haven’t any holdings within the fast-growing nanotech sector. Particularly, analysts mission it’s going to see a compound annual progress price of 34.7% by 2032.

Due to this fact, I’ll purchase the inventory very quickly.

Related articles

Aramark Q4 2026 EPS Tops Expectations, Revenue Up 5%

November 16, 2026

£3k buys 903 shares in this passive income stock yielding 6.2%

November 16, 2026


Person holding magnifying glass over important document, reading the small print

Picture supply: Getty Photos

FTSE 250 hi-tech agency Oxford Devices (LSE: OXIG) is down 29% from its 15 July one-year traded excessive of £26.

It was established in 1959 when it was spun off from Oxford College’s physics division. An early success was its pioneering function within the improvement of magnetic resonance imaging scans utilized in medical prognosis.

Since then it has been on the slicing fringe of the design and manufacture of high-tech merchandise for scientific and industrial use.

Most notably maybe, it’s a world chief in nanotechnology. This includes manipulating matter on the atomic and molecular stage to create new supplies and units. 

Why has the share worth dropped?

A key motive behind its current share worth decline was information that it has agreed to promote its NanoScience enterprise.

Nevertheless, it is very important observe that this solely contains a part of the agency’s nanotechnology pursuits. Particularly, the bit that makes particular models to supercool quantum computer systems.

The agency highlights that the sale will enhance its margin by 1.9% enhance by permitting it to deal with three core structural progress markets. These are supplies evaluation, semiconductor, and healthcare & life science.

Furthermore, as much as £50m of the proceeds from the divestment will go to a share buyback. These are usually supportive of share worth positive aspects.

The newest outcomes

The agency’s full fiscal 12 months 2024/25 outcomes noticed income rise 6.5% 12 months on 12 months to £500.6m. This was the primary time income had breached the £500m barrier.

Working revenue elevated 10.8% to £82.2m, whereas adjusted revenue margin edged up 0.7% to 17.8%.

Income is a agency’s complete revenue, whereas earnings (or ‘revenue’) are what stays after bills have been deducted.

A threat for the agency is a significant failure in considered one of its key merchandise. This may harm its popularity and be expensive to repair.

That stated, consensus analysts’ forecasts are that its earnings will rise by a whopping 32.4% every year to end-fiscal 12 months 2027/28.

Are the shares undervalued?

The primary a part of my evaluation of the agency’s share worth is to match its key valuations with these of its rivals.

On the price-to-sales ratio, Oxford Devices’ 2.1 studying is undervalued in comparison with its friends’ common of two.7. These comprise Bruker at 1.7, Renishaw at 2.8. Spectris at 2.9, and Thermo Fisher Scientific at 3.5.

Nevertheless, it seems overvalued at a price-to-earnings ratio of 39.7 in comparison with its peer group’s 33.3 common.

The second a part of my evaluation includes operating a discounted money circulation (DCF) evaluation. That is primarily based on money circulation forecasts for the underlying enterprise and pinpoints the place any agency’s share worth must be.

Utilizing different analysts’ figures and my very own, the DCF for Oxford Devices reveals its shares are 40% undervalued at £18.44.

Due to this fact, their truthful worth is £30.73.

My view

I’m often centered on shares that ship a excessive dividend yield, whereas Oxford Devices solely pays 1.2% at current.

Nevertheless, its very sturdy earnings progress potential ought to energy its share worth and dividend a lot larger over time.

I additionally haven’t any holdings within the fast-growing nanotech sector. Particularly, analysts mission it’s going to see a compound annual progress price of 34.7% by 2032.

Due to this fact, I’ll purchase the inventory very quickly.

Tags: AnnualfirmForecastFTSEfullyeargemGrowthHiddennanotechresultsstrong
Share76Tweet47

Related Posts

Aramark Q4 2026 EPS Tops Expectations, Revenue Up 5%

by Coininsight
November 16, 2026
0

AlphaStreet Newsdesk powered by AlphaStreet Intelligence Related Coverage Preview Aramark (ARMK) Q4 2026 Preview: EPS Est. $0.49, Reports November 16...

£3k buys 903 shares in this passive income stock yielding 6.2%

by Coininsight
November 16, 2026
0

Image source: Getty Images How much passive income could £3k earn in the stock market? At the moment, the FTSE...

Natural Alternatives International (NAII) Reports Q1 2027 Numbers

by Coininsight
November 15, 2026
0

AlphaStreet Newsdesk powered by AlphaStreet Intelligence NAII|EPS -$0.41|Rev $28.1M|Net Loss $2.5M Natural Alternatives International, Inc. (NAII) posted Q1 2027 diluted...

£20,000 invested in a Stocks and Shares ISA 10 years ago is now worth…

by Coininsight
November 14, 2026
0

It has been almost 10 years since the Stocks and Shares ISA allowance was bumped up to £20,000 a year....

Stock market news for Nov. 13, 2026

by Coininsight
November 13, 2026
0

Traders work at the New York Stock Exchange, Nov. 10, 2026. NYSEThe Nasdaq Composite fell on Friday as Nvidia shares...

Load More
  • Trending
  • Comments
  • Latest
What’s Actually Going On With Ripple’s Blockchain?

What’s Actually Going On With Ripple’s Blockchain?

January 12, 2026

Grantee Roundup: November 2020 | Ethereum Foundation Blog

September 28, 2026
MetaMask Launches An NFT Reward Program – Right here’s Extra Data..

MetaMask Launches An NFT Reward Program – Right here’s Extra Data..

July 24, 2025
Finest Bitaxe Gamma 601 Overclock Settings & Tuning Information

Finest Bitaxe Gamma 601 Overclock Settings & Tuning Information

November 26, 2025
Kuwait bans Bitcoin mining over power issues and authorized violations

Kuwait bans Bitcoin mining over power issues and authorized violations

2
The Ethereum Basis’s Imaginative and prescient | Ethereum Basis Weblog

The Ethereum Basis’s Imaginative and prescient | Ethereum Basis Weblog

2
Unchained Launches Multi-Million Greenback Bitcoin Legacy Mission

Unchained Launches Multi-Million Greenback Bitcoin Legacy Mission

1
Earnings Preview: Microsoft anticipated to report larger Q3 income, revenue

Earnings Preview: Microsoft anticipated to report larger Q3 income, revenue

1

Responsible AI Is a Culture, Not a Policy

November 16, 2026

Aramark Q4 2026 EPS Tops Expectations, Revenue Up 5%

November 16, 2026

Complete Guide to Spot Bitcoin ETFs: Safely Invest in 2026

November 16, 2026

23.5% of Peak Inflows Gone

November 16, 2026

CoinInight

Welcome to CoinInsight.co.uk – your trusted source for all things cryptocurrency! We are passionate about educating and informing our audience on the rapidly evolving world of digital assets, blockchain technology, and the future of finance.

Categories

  • Bitcoin
  • Blockchain
  • Crypto Mining
  • Ethereum
  • Future of Crypto
  • Market
  • Regulation
  • Ripple

Recent News

Responsible AI Is a Culture, Not a Policy

November 16, 2026

Aramark Q4 2026 EPS Tops Expectations, Revenue Up 5%

November 16, 2026
  • About
  • Privacy Poilicy
  • Disclaimer
  • Contact

© 2025- https://coininsight.co.uk/ - All Rights Reserved

No Result
View All Result
  • Home
  • Bitcoin
  • Ethereum
  • Regulation
  • Market
  • Blockchain
  • Ripple
  • Future of Crypto
  • Crypto Mining

© 2025- https://coininsight.co.uk/ - All Rights Reserved

Social Media Auto Publish Powered By : XYZScripts.com
Verified by MonsterInsights